Treatment response in metastatic breast cancer. A multicentre study comparing UICC criteria and tumour marker changes
- 30 April 1996
- journal article
- Published by Elsevier in The Breast
- Vol. 5 (2) , 82-88
- https://doi.org/10.1016/s0960-9776(96)90126-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Monoclonal Antibody M3 Used in Tissue Polypeptide–Specific Antigen Assay for the Quantification of Tissue Polypeptide Antigen Recognizes Keratin 18Tumor Biology, 1994
- Diagnostic Value of Tissue Polypeptide Specific Antigen in Patients with Pancreatic CarcinomaTumor Biology, 1994
- Serological Markers for Metastatic Breast CancerDisease Markers, 1993
- CA 15-3 in patients with locoregional and metastatic breast carcinomaCancer, 1992
- Serum markers in breast cancer managementThe Breast, 1992
- Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tractZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- TPS in Breast Cancer – A Comparative Study with Carcinoembryonic Antigen and CA 15-3Tumor Biology, 1992
- The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigenCancer, 1991
- Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patientsBritish Journal of Cancer, 1991
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977